Therapeutic Asset Ratings

8,399 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Pralsetinib, trans- RET Fusion Positive Cancer	Fudan University	P1/2	CCC (52)
PREDNISONE TABLETS Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8	National Cancer Institute (NCI)	P1/2	CCC (52)
PREDNISONE TABLETS Lymphoid Neoplasm	National Cancer Institute (NCI)	P1/2	CCC (52)
PREDNISONE TABLETS Skin Basal Cell Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (52)
PRILOCAINE Memory Disorders in Old Age	University of Dublin, Trinity College	P1/2	CCC (52)
PRILOCAINE Amnestic Disorder	University of Dublin, Trinity College	P1/2	CCC (52)
Promethazine DLBCL	Institute of Hematology & Blood Diseases Hospital, China	P1/2	CCC (52)
PSMA I&T Nonpapillary Renal Cell Carcinoma	Centre Leon Berard	P1/2	CCC (52)
Pyrotinib Peritoneal Metastases	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	P1/2	CCC (52)
Quaratusugene Ozeplasmid Non-Small Cell Lung Carcinoma	Genprex, Inc.	P1/2	CCC (52)
Rapamycin Melanoma	National Cancer Institute (NCI)	P1/2	CCC (52)
rc48-adc Peritoneal Metastases	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	P1/2	CCC (52)
Retifanlimab Follicular Lymphoma	University of Alabama at Birmingham	P1/2	CCC (52)
Ribociclib Cancer	OnKure, Inc.	P1/2	CCC (52)
Ribociclib Advanced Solid Tumors	OnKure, Inc.	P1/2	CCC (52)
Rsp-1502 Cystic Fibrosis	Respirion Pharmaceuticals Pty Ltd	P1/2	CCC (52)
Rsp-1502 Pseudomonas Aeruginosa Infectious Disease	Respirion Pharmaceuticals Pty Ltd	P1/2	CCC (52)
Ruxolitinib Malignant Atrophic Papulosis	National Heart, Lung, and Blood Institute (NHLBI)	P1/2	CCC (52)
Selenium Nonpapillary Renal Cell Carcinoma	Mohammed Milhem	P1/2	CCC (52)
SODIUM P-AMINOHIPPURATE Diabetic Kidney Disease	University of Colorado, Denver	P1/2	CCC (52)
Spk-8016 Hemophilia A	Spark Therapeutics, Inc.	P1/2	CCC (52)
sr604 Hemophilia B	Shanghai RAAS Blood Products Co., Ltd.	P1/2	CCC (52)
Surufatinib Soft Tissue Sarcoma	Hutchmed	P1/2	CCC (52)
Talzenna Acute Myeloid Leukemia	German Cancer Research Center	P1/2	CCC (52)
Talzenna Ewing Sarcoma	St. Jude Children's Research Hospital	P1/2	CCC (52)

Showing 651 to 675 of 8,399 assets

PreviousPage 27 of 336Next